Overview
Updated 14 Jul 2026
Janet McGill, MD, is Professor of Medicine, Division of Endocrinology, Metabolism & Lipid Research at Washington University in St. Louis (Washington University School of Medicine). The public record shows 418 publications with 28,962 citations (h-index 86), centered on Diabetes Treatment and Management, Diabetes Management and Research, Pancreatic function and diabetes. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 29 companies, 2 NIH-funded awards (1990–2007).
- Most recent indexed publication: 2026 · Diabetes, obesity & metabolism
- Top research focus: Diabetes Treatment and Management
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 29 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 234.
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- Participant
FDA Clinical Chemistry and Clinical Toxicology Devices Panel meeting on continuous glucose monitoring (Dexcom G5) review
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mobihealthnews.com ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Sponsor: COUR Pharmaceutical Development Company, Inc.
InvestigatorPhase 1/PHASE2RecruitingNCT06783309 - Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Sponsor: Alessandro Doria
InvestigatorPhase 3RecruitingNCT06217302 - Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency
Sponsor: Washington University School of Medicine
InvestigatorPhase 4CompletedNCT05541484
Industry payments
Updated 14 Jul 2026
29 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20256 payments
- Mannkind CorporationProgram year20259 payments
- PFIZER INC.Program year20251 payment
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 1990–2007 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
Hypertension (Dallas, Tex.
2026 - Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial.
Journal of the American Society of Nephrology
2026 - Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone.
Journal of the American Society of Nephrology
2026 - Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations.
Nephrology, dialysis, transplantation
2026
Most-cited worksby citation count (OpenAlex)
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
4921 Parkview Place, Floor 13, Suite B, St. Louis, MO 63110
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD
Michigan State University College of Human Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.wustl.edu ↗ - MA
Northern Michigan University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physicians.wustl.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.wustl.edu ↗
- Residency and Chief Residency in Internal Medicine
William Beaumont Hospital (Royal Oak, MI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.wustl.edu ↗ - Fellowship in Endocrinology and Metabolism
Washington University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.wustl.edu ↗
- Former Director
Fellowship in Endocrinology, Diabetes and Metabolism, Washington University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physicians.wustl.edu ↗ - Principal Investigator
NIH-funded GRADE study (Washington University site)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wustl.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →professional.diabetes.org ↗
- Distinguished Clinician Award
Washington University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗ - Alumni Achievement Award
Washington University School of Medicine (HS '87)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗
Secondary affiliationsappointments beyond the home institution
- Attending Physician
Barnes-Jewish Hospital, St. Louis, MO
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicians.wustl.edu ↗
Media & interviewspress, podcasts and appearances
- "Finerenone Marks a Breakthrough for Kidney Protection in Type 1 Diabetes, with Janet McGill, MD, MA"
video interview, HCPLive
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗ - "Multifaceted Approach to Type 2 Diabetes Care"
Medscape/Reference video feature
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reference.medscape.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/janet-mcgill-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Janet-Mcgill-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- X / Twitter
x.com/WashUMedEndo/status/1999235738144014549
- X / Twitter
x.com/WashUVFH/status/1998426110904692794
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Van Cutsem, MD, PhD
Universitair Ziekenhuis Leuven
- 1,845
- publications
- 177
- h-index
- 14
- trials
Josep Tabernero, MD, PhD
Vall d'Hebron Institut de Recerca
- 2,704
- publications
- 148
- h-index
- 19
- trials
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
- 1,745
- publications
- 154
- h-index
- 22
- trials
Charles Fuchs, MD, MPH
Yale Cancer Center
- 1,721
- publications
- 172
- h-index
- 7
- trials